Saliva Collection Device (BSC91)

Hangzhou, Zhejiang, China

The company is a leading provider of life science and medical diagnostic products in China, specializing in the research and development, production and sales of a series of molecular testing products, and is committed to providing comprehensive molecular testing laboratory solutions for clinical and non-clinical customers. We are rooted in China and have a global presence. We have an industry-leading global and cross-field R D team, covering various professional and technical talents in software design, structure, circuits, medicine, biology, agronomy, etc. We combine technological innovation with market demand The understanding has been fully integrated, and Zhejiang Bior Molecular Biotechnology Research Institute, Zhejiang University-Bori Technology Joint Research Center, Zhejiang Provincial Center for Disease Control and Prevention-Bori Technology Research Center for Infectious Disease Principles and Detection Key Technologies , and Bior Technology Japan Science and Technology Zhejiang Province Postdoctoral Workstation and other research institutions. We are one of the leaders and pioneers in China's PCR industry . We are one of the first companies in China to obtain a registration certificate for fluorescence quantitative PCR equipment. We have now developed into a comprehensive supplier of molecular testing with multiple technology platforms and multiple product lines. We have developed And mass-produce real-time fluorescence quantitative PCR analyzers, fully automatic nucleic acid purifiers, gene amplifiers, nucleic acid purification reagents, various PCR detection reagents, standard PCR testing laboratories, mobile PCR testing laboratories, sample preservation solutions, consumables, and raw materials and other products, forming an ecosystem of “instruments + reagents + consumables + raw materials”, strategically covering the entire PCR industry value chain. In the future, we will implement the development strategy of vertical deep cultivation and horizontal expansion , continue to focus on molecular detection technology vertically, and realize the automation , integration, miniaturization and digitization of PCR detection platforms as well as the industrialization of multi-category detection reagents and consumables. After implementation, it will expand horizontally to the direction of multi-methodological in vitro diagnostic technology and industrial upstream raw materials, further enriching product lines and application fields. We actively fulfill our social responsibilities and have participated in anti-epidemic and disaster relief work such as SARS in 2003 , H1N1 in 2009 , African swine fever in 2018, and plague in Inner Mongolia in 2019 . In the face of the new coronavirus epidemic that is raging around the world, the company responded to the national call and launched a complete set of new coronavirus solutions as soon as possible, actively participated in epidemic prevention and control, and donated millions of yuan in supplies to fight the epidemic, providing services to 34 provincial administrative regions across the country and the world. The construction of large-scale nucleic acid testing bases in many countries and regions has provided key nucleic acid testing fluorescence quantitative PCR equipment and reagents, playing an important role in global epidemic prevention and control. Over the years, Bioer has been committed to technological innovation and equipment innovation in the field of molecular testing , striving to improve global human health and well-being. Today, we have developed into an international global enterprise with multiple subsidiaries and more than 1,000 employees. Our business covers more than 120 countries and regions around the world . Our comprehensive solutions have expanded to medical diagnosis, animal husbandry and fishery, scientific research, food Security, customs disease control and other key areas have benefited hundreds of millions of users. Today, we will adhere to the business philosophy of diligence and determination, pioneering and excellence , continue to expand application fields and industries, continue to update and improve product pipelines, lead development with innovation, use technology to care for life, and better serve customers and society. , from China to the world, benefiting the whole world.